|
|
The Clinical Effect of Benzbromarone Combined with Glucocorticoid Therapy on Patients with Gouty Arthritis and It's Influence on AST ALT UA Level |
LU Xiaojing, ZHOU Zhi'an, SU Bin |
Chengde Central Hospital, Hebei Chengde 067000, China |
|
|
Abstract Objective: To investigate the effect of benzbromarone combined with glucocorticoid therapy on patients with gouty arthritis and its influence on the level of AST, ALT and UA. Methods: 300 patients with gouty arthritis who were treated in our hospital from February 2019 to February 2020 were selected as the research objects, and they were randomly divided into group A and group B with 150 cases each. Group A was treated with colchicine + Glucocorticoid therapy, group B was treated with benzbromarone combined with glucocorticoid, and the clinical efficacy and the changes of AST, ALT and UA levels were compared between the two groups. Results: In group A, 78 cases were markedly effective, 50 cases effective, 22 cases ineffective, and the total effective rate was 85.33%; Group B patients had 80 markedly effective cases, 60 cases effective , and 10 cases ineffective, with a total effective rate of 93.33%; The effective rate was analyzed by clinical statistics, and there was a difference (P<0.05); The two groups of patients had no statistical difference in age, gender, and BMI indicators (P>0.05); And among the ALT, AST, UA indicators, group B indicators were significantly better than group A, with significant statistical difference (P<0.05). Conclusion: Benzbromarone combined with glucocorticoid therapy in patients with gouty arthritis has a significant clinical effect on patients. At the same time, attention should be paid to monitoring changes in liver function.
|
|
|
|
|
[1] 刘鑫琦.非诺贝特联合非布司他/苯溴马龙治疗痛风伴高甘油三酯症的有效性与安全性研究[D].青岛,青岛大学,2019. [2] 白煜佳.痛风性关节炎患者血清及组织中IL-17水平研究[D].北京,北京协和医学院,2015. [3] 梁广宇.痛风患者随访情况分析及慢性痛风性关节炎患者IL-17表达水平探究[D].北京,北京协和医学院,2016. [4] 李寅.马宝东教授对急性痛风性关节炎治疗浅谈[D].辽宁,辽宁中医药大学,2014. [5] 夏剑辉.小剂量苯溴马隆在中年高血压伴高尿酸血症患者的应用[J].黑龙江医药,2018,31(2):283~285. [6] 韦隽,陈庆云.糖皮质激素在急性痛风性关节炎中的临床疗效探讨[J].临床医药文献电子杂志,2019,6(8):61~62. [7] 王海波,崔永虹.小剂量秋水仙碱联合复方倍他米松注射液治疗痛风性关节炎急性期的临床分析[J].现代医学与健康研究电子杂志,2018,2(9):62. [8] Kushiyama A,Tanaka K,Hara S,et al. Linking uric acid metabo-lism to diabetic complications [J]. World Diabetes,2014,5 ( 6 ) :787~795. [9] Braga F,Pasqualetti S,Ferraro S,et al. Hyperuricemia as risk factorfor coronary heart disease incidence and mortality in the general popu-lation: a systematic review and Meta - analysis [J]. Clin Chem LabMed,2016,54( 1) : 7 ~ 15. |
|
|
|